These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34947984)

  • 1. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
    Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine.
    Sambon M; Wins P; Bettendorff L
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.
    Milos T; Rojo D; Nedic Erjavec G; Konjevod M; Tudor L; Vuic B; Svob Strac D; Uzun S; Mimica N; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Nikolac Perkovic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110830. PubMed ID: 37454721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
    Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
    Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metabolomic study based on accurate mass and isotopic fine structures by dual mode combined-FT-ICR-MS to explore the effects of Rhodiola crenulata extract on Alzheimer disease in rats.
    Zhang X; Jiang X; Wang X; Zhao Y; Jia L; Chen F; Yin R; Han F
    J Pharm Biomed Anal; 2019 Mar; 166():347-356. PubMed ID: 30690248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
    González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL
    Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis.
    Pan X; Fei G; Lu J; Jin L; Pan S; Chen Z; Wang C; Sang S; Liu H; Hu W; Zhang H; Wang H; Wang Z; Tan Q; Qin Y; Zhang Q; Xie X; Ji Y; Cui D; Gu X; Xu J; Yu Y; Zhong C
    EBioMedicine; 2016 Jan; 3():155-162. PubMed ID: 26870826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism.
    Akyol S; Ugur Z; Yilmaz A; Ustun I; Gorti SKK; Oh K; McGuinness B; Passmore P; Kehoe PG; Maddens ME; Green BD; Graham SF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
    Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
    Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Oberacher H; Arnhard K; Linhart C; Diwo A; Marksteiner J; Humpel C
    J Alzheimers Dis; 2017; 57(2):493-504. PubMed ID: 28269764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
    J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.